The effect of intravesical Bacillus Calmette-Guerin instillations on the expression of inducible nitric oxide synthase in humans

Nitric Oxide - Biology and Chemistry

Volumn 13, Issue 1, 2005, Pages 36-41

  Mitropoulos, Dionisios ^a   Petsis, Dimitrios ^a   Kyroudi Voulgari, Aspasia ^a   Kouloukoussa, Mirsini ^a   Zervas, Anastasios ^a   Dimopoulos, Constantinos ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

BCG; Bladder carcinoma; Nitric oxide synthase

Indexed keywords

ANTINEOPLASTIC AGENT; BCG VACCINE; INDUCIBLE NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE;

ADULT; AGED; ANTINEOPLASTIC ACTIVITY; ARTICLE; BLADDER; BLADDER CARCINOMA; CANCER CELL; CANCER RECURRENCE; CANCER SURGERY; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG INSTILLATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOTHERAPY; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSURETHRAL RESECTION; UPREGULATION; UROTHELIUM;

ADJUVANTS, IMMUNOLOGIC; ADMINISTRATION, INTRAVESICAL; ANIMALS; BCG VACCINE; CARCINOMA, TRANSITIONAL CELL; HUMANS; IMMUNOHISTOCHEMISTRY; NEOPLASM RECURRENCE, LOCAL; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; URINARY BLADDER; URINARY BLADDER NEOPLASMS; UROTHELIUM;

MYCOBACTERIUM BOVIS BCG;

EID: 20744458070     PISSN: 10898603     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.niox.2005.04.012     Document Type: Article

References (52)

1. H. Akaza, S. Hinotsu, Y. Aso, T. Kakizoe, and K. Koiso for the Bladder Cancer BCG study Group, Bacillus Calmette-Guerin treatment of existing papillary bladder cancer and carcinoma in situ of the bladder Cancer 75 1995 552 559
2. D.L. Lamm BCG in perspective: advances in the treatment of superficial bladder cancer Eur. Urol. 27 Suppl. 1 1995 2 8
3. A. Morales, D. Eidinger, and A.W. Bruce Intracavitary Bacillus Calmette-Guerin in the treatment of superficial bladder tumors J. Urol. 116 1976 180 183
4. K. Sarica, S. Baltaci, Y. Beduk, O. Suzer, S. Kilic, Y. Ziya Muftuoglu, and O. Gogus Evaluation of cellular immunity following Bacillus Calmette-Guerin therapy in patients with superficial bladder cancer Urol. Int. 54 1995 137 141
5. K. Yoshimura, and T. Yamauchi Influence of intravesical bacillus Calmette-Guerin therapy on systemic immunological status Int. J. Urol. 4 1997 456 460
6. E. Reyes, J. Carballido, L. Manzano, L. Molto, C. Olivier, and M. Alvarez-Mon The association between CD2+ peripheral blood lymphocyte subsets and the relapse of bladder cancer in prophylactically BCG-treated patients Br. J. Cancer 79 1999 1162 1167
7. K. Taniguchi, S. Koga, M. Nishikido, S. Yamashita, T. Sakuragi, H. Kanetake, and Y. Saito Systemic immune response after intravesical instillation of bacilli Calmette-Guerin (BCG) for superficial bladder cancer Clin. Exp. Immunol. 115 1999 131 135
8. U. Elsasser-Beile, O. Gutzeit, S. Bauer, A. Katzenwadel, W. Schultze-Seemann, and U. Wettereauer Systemic and local immunomodulatory effects of intravesical BCG therapy in patients with superficial urinary bladder carcinomas J. Urol. 163 2000 296 299
9. C. Magno, D. Melloni, A. Gali, G. Mucciardi, G. Nicocia, B. Morandi, G. Melioli, and G. Ferlazzo The anti-tumor activity of bacillus Calmette-Guerin in bladder cancer is associated with an increase in the circulating level of interleukin-2 Immunol. Lett. 81 2002 235 238
10. M. Reale, R. Intorno, R. Tenaglia, C. Feliciani, R.C. Barbacane, A. Santoni, and P. Conti Production of MCP-1 and RANTES in bladder cancer patients after bacillus Calmette-Guerin immunotherapy Cancer Immunol. Immunother. 51 2002 91 98
11. D. Mitropoulos, G. Deliconstantinos, A. Zervas, A. Giannopoulos, G. Kyriakou, and C. Dimopoulos Oxidative stress of red blood cells during Bacillus Calmette-Guerin intravesical instillations In vivo 14 2000 721 724
12. A. Böhle, and S. Brandau Immune mechanisms in Bacillus Calmette-Guerin immunotherapy for superficial bladder cancer J. Urol. 170 2003 964 969
13. S. Prescott, A.M. Jackson, S.J. Hawkyard, A.B. Alexandroff, and K. James Mechanisms of action of intravesical Bacille Calmette-Guerin: local immune mechanisms Clin. Infect. Dis. 31 Suppl. 3 2000 S91 S93
14. J.J. Patard, F. Saint, F. Velotti, C.C. Abbou, and D.K. Chopin Immune response following intravesical bacillus Calmette-Guerin instillations in superficial bladder cancer: a review Urol. Res. 26 1998 155 159
15. R.F.M. Bevers, K.-H. Kurth, and D.H.J. Schamhart Role of urothelial cells in BCG immunotherapy for superficial bladder cancer Br. J. Cancer 91 2004 607 612
16. R.G. Knowles, and S. Moncada Nitric oxide synthases in mammals Biochem. J. 298 1994 249 258
17. S. Moncada, and A. Higgs The l-arginine nitric oxide pathway N. Engl. J. Med. 329 1993 2002 2012
18. M.A. Wheeler, S.D. Smith, G. Garcia-Gardena, C.F. Nathan, R.M. Weiss, and W.C. Sessa Bacterial infection induces nitric oxide synthase in human neutrophils J. Clin. Invest. 99 1997 110 116
19. M.E. De Vera, R.A. Shapiro, A.K. Nussler, J.S. Mudgett, R.L. Simmons, S.M. Morris Jr, T.R. Billiar, and D.A. Geller Transcriptional regulation of human inducible nitric oxide synthase (NOS2) gene by cytokines: initial analysis of the human NOS2 promoter Proc. Natl. Acad. Sci. USA 93 1996 1054 1059
20. H.S. Swana, S.D. Smith, P.L. Perrota, N. Saito, M.A. Wheeler, and R.M. Weiss Inducible nitric oxide synthase with transitional cell carcinoma of the bladder J. Urol. 161 1999 630 634
21. T. Klotz, W. Bloch, G. Jacobs, S. Niggemann, U. Engelmann, and K. Addicks Immunolocalization of inducible and constitutive nitric oxide synthases in human bladder cancer Urology 54 1999 416 419
22. H. Wolf, C. Haeckel, and A. Roessner Inducible nitric oxide synthase expression in human urinary bladder cancer Virchows Arch. 437 2000 662 666
23. M. Shochina, Y. Fellig, M. Sughayer, G. Pizov, K. Vitner, D. Poteh, A. Hochberg, and I. Ariel Nitric oxide synthase immunoreactivity in human bladder carcinoma J. Clin. Pathol: Mol. Pathol. 54 2001 248 252
24. A. Ehsan, F. Sommer, A. Schmidt, T. Klotz, J. Koslowski, S. Niggermann, G. Jacobs, U. Engelmann, K. Addicks, and W. Bloch Nitric oxide pathways in human bladder carcinoma: The distribution of nitric oxide synthases, soluble guanyl cyclase, cyclic guanosine monophosphate, and nitrotyrosine Cancer 95 2002 2293 2301
25. A.M. Eijan, I. Piccardo, M.D. Riveros, E.O. Sandes, H. Porcella, M.A. Jasnis, E.S. De Lusting, H. Malagrino, L. Pasik, and A.R. Casabe Nitric oxide in patients with transitional bladder cancer J. Surg. Oncol. 81 2002 203 208
26. D. Mitropoulos, G. Deliconstantinos, M. Chrisofos, J. Garifallos, A. Zervas, C. Dimopoulos, J. Stavrides. Estimation of nitric oxide and nitrite in serum and urine of bladder cancer patients, Abstract book, XIth Congress of the European Association of Urology Congress, Berlin, 1994, p. 342.
27. E. Morcos, O.T. Jansson, J. Adolfsson, G. Kratz, and N.P. Wiklund Endogenously formed nitric oxide modulates cell growth in bladder cancer cell lines Urology 53 1999 1252 1257
28. A. Konur, S.W. Krause, M. Rehli, M. Kreutz, and R. Anreesen Human monocytes induce a carcinoma cell line to secrete high amounts of nitric oxide J. Immunol. 157 1996 2015 2109
29. J.O.N. Lundberg, I. Ehren, O. Jansson, J. Adolfsson, J.M. Lundberg, E. Weitzberg, K. Alving, and N.P. Wiklund Elevated nitric oxide in the urinary bladder in infectious and noninfectious cystitis Urology 48 1996 700 702
30. O.T. Jansson, E. Morcos, L. Brundin, J.O.N. Lundberg, J. Adolfsson, M. Soderhall, and N.P. Wiklund The role of nitric oxide in bacillus Calmette-Guerin mediated antitumor effects in human bladder cancer Br. J. Cancer 78 1998 588 592
31. B.R. Oh, K. Nakajima, K.Y. Ahn, S.B. Ryu, Y.I. Park, and R. Dahiya Nitric oxide synthase gene and protein expression are upregulated by bacille Calmette-Guerin in the rat bladder Eur. Urol. 39 2001 349 356
32. E. Morcos, O.T. Jansson, J. Adolfsson, I. Ehren, and N.P. Wiklund Bacillus Calmette-Guerin induces long-term local formation of nitric oxide in the bladder via the induction of nitric oxide synthase activity in urothelial cells J. Urol. 165 2001 678 682
33. W.Q. Xie, H.J. Cho, J. Calaycay, R.A. Mumford, K.M. Swiderek, T.D. Lee, A. Ding, T. Troso, and C. Nathan Cloning and characterization of inducible nitric oxide synthase from mouse macrophages Science 256 1992 225 228
34. P. Rajala, E. Kaasinen, E. Rintala, K. Jauhiainen, M. Nurmi, O. Alfthan, and M. Lahde M Cytostatic effect of different strains of Bacillus Calmette-Guerin on human bladder cancer cells in vitro alone and in combination with mitomycin C and interferon-alpha Urol. Res. 20 1992 215 217
35. A.M. Jackson, A.B. Alexandroff, D. Fleming, S. Prescott, G.D. Chisholm, and K. James Bacillus Calmette-Guerin (BCG) organisms directly alter the growth of bladder tumor cells Int. J. Oncol. 5 1994 697 703
36. K. Pryor, P. Stricker, P. Russell, D. Golovsky, and R. Penny Antiproliferative effects of bacillus Calmette-Guerin and interferon alpha-2b on human bladder cancer cells in vitro Cancer Immunol. Immunother. 41 1995 309 316
37. Y. Zhang, H.E. Khoo, and K. Esuvaranathan Effects of bacillus Calmette-Guerin and interferon-α -2B on human bladder cancer cells in vitro Int. J. Cancer 71 1997 851 857
38. A. Sasaki, S. Kudoh, K. Mori, N. Takahashi, and T. Suzuki T Are BCG effects against urinary bladder carcinoma cell line T24 correlated with apoptosis in vitro Urol. Int. 59 1997 142 148
39. H. Saitoh, K. Mori, S. Kudoh, H. Itoh, N. Takahashi, and T. Suzuki BCG effects on telomerase activity in bladder cancer cell lines Int. J. Clin. Oncol. 7 2002 165 170
40. F. Saint, J.J. Patard, P. Maille, P. Soyeux, A. Hoznek, L. Salomon, A. dela Taille, C.C. Abbou, and D.K. Chopin T helper 1/2 lymphocyte urinary cytokine profiles in responding and nonresponding patients after 1 and 2 courses of bacillus Calmette-Guerin for superficial bladder cancer J. Urol. 166 2001 2142 2147
41. J.D. Fleischmann, Z. Toossi, J.J. Ellner, D.B. Wentworth, T.L. Ratliff, and A.L. Imbembo Urinary interleukins in patients receiving intravesical Bacillus Calmette-Guerin therapy for superficial bladder cancer Cancer 64 1989 1447 1454
42. A.M. Jackson, A.V. Ivshina, O. Senko, A. Kuznetsova, A. Sundan, M.A. O'Donnell, S. Clinton, A.B. Alexandroff, P.J. Selby, K. James, and V.A. Kuznetsov Prognosis of intravesical bacillus Calmette-Guerin therapy for superficial bladder cancer by immunological urinary measurements: statistically weighted syndromes analysis J. Urol. 159 1998 1054 1063
43. J.-Y. Kwak, M.K. Han, K.-S. Choi, I.-H. Park, S.-Y. Park, M.-H. Sohn, U.-H. Kim, J.R. McGregor, W.E. Samlowski, and C.-Y. Yim Cytokines secreted by lymphokine-activated killer cells induce endogenous nitric oxide synthesis and apoptosis in DLD-1 colon cancer cells Cell Immunol. 203 2000 84 94
44. H. Ischiropoulos, L. Zhu, Z. Chen, M. Tsai, J.C. Martin, C.D. Smith, and J.S. Beckman Peroxynitrite-mediated tyrosine nitration catalyzed by superoxide dismutase Arch. Biochem. Biophys. 298 1992 431 437
45. D.C. Jenkins, I.G. Charles, L.L. Thomsen, D.W. Moss, L.S. Holmes, S.A. Baylis, P. Rhodes, K. Westmore, P.C. Emson, and S. Moncada Roles of nitric oxide in tumor growth Proc. Natl. Acad. Sci. USA 92 1995 4392 4396
46. R. Farias-Eisner, M.P. Sherman, E. Aeberhard, and G. Chaudhuri Nitric oxide is an important mediator for tumoricidal activity in vivo Proc. Natl. Acad. Sci. USA 91 1994 9407 9411
47. Z.P. Wang, Y.R. Chen, R.L. Zheng, J.L. Lu, and J.J. Wang Effects of reactive oxygen species on lymphokine-activated killer cells in patients with bladder cancer Acta Pharmacol. Sin. 23 2002 257 262
48. J.S. Teppema, E.C. de Boer, P.A. Steerenberg, and A.P. van der Meijden Morphological aspects of the interaction of Bacillus Calmette-Guerin with urothelial bladder cells in vivo and in vitro: relevance for antitumor activity? Urol. Res. 20 1992 219 228
49. C. Durek, S. Brandau, A.J. Ulmer, H.D. Flad, D. Jocham, and A. Bohle Bacillus Calmette-Guerin (BCG) and 3D tumors: an in vitro model for the study of adhesion and invasion J. Urol. 162 1999 600 605
50. W.E. Samlowski, C.-Y. Yim, and J.R. McGregor Nitric oxide exposure inhibits induction of lymphokine-activated killer cells by inducing precursor apoptosis Nitric Oxide 2 1998 45 56
51. H. Yamada, S. Matsumoto, T. Matsumoto, T. Yamada, and U. Yamashita Enhancing effect of an inhibitor of nitric oxide synthesis on bacillus Calmette-Guerin-induced macrophage cytotoxicity against murine bladder cancer cell line MBT-2 in vitro Jpn. J. Cancer Res. 91 2000 534 542
52. + T cells by a mechanism requiring cell contact and mediated by both the cell-associated form of TNF and nitric oxide J. Immunol. 167 2001 5583 5593